Duke Early Phase Clinical Research

Durham, North Carolina 27710

1 studies enrolling now · 6 studies all time

What they study most

Cardiovascular, Clostridium Difficile Infection, Dyslipidemias, Epigenetics, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), Hypercholesterolaemia, Hyperinsulinemic Hypoglycemia, Hypertriglyceridemia, Lipid Disorder, Major Depressive Disorder, Metabolic Disease

Studies at this site

• A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias — Recruiting now
• Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine — Completed
• Biomarker Study to Evaluate Correlations Between Epigenetic Aging and NAD+ Levels in Healthy Volunteers — Paused
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia — Completed
• Glucagon Ready to Use (RTU) in Subjects With Hyperinsulinemic Hypoglycemia After Bariatric Surgery — Completed